Adding cetuximab to chemotherapy led to worse outcomes for patients with resectable liver metastases caused by colorectal cancer, updated data from the New EPOC trial showed.
[Cancer Management and Research] Use of inflammatory indices, particularly C-reactive protein/albumin ratio (CAR), is effective in predicting risk for postoperative complications in patients undergoing resection of colorectal cancer.
Patients older than 25 years have significantly higher rates of OS and RFS at 3 and 5 years compared with patients younger than 25.
Suspected local disease regrowth was seen in 23% of patients with rectal cancer observed following a near or complete clinical response to neoadjuvant therapy.
These findings have implications for the screening of survivors of childhood or young adult-related cancers that are independent of prior abdominopelvic radiation therapy.
Findings seen for colorectal cancer, but no similar findings found for advanced breast cancer diagnoses.
Lower GI bleeding in patients with atrial fibrillation who receive anticoagulation therapy should prompt tests to rule out colorectal cancer, findings from this study have shown.
[Cancer Management and Research] This retrospective analysis sought to determine the predictive value of GNRI in determining postoperative complication risk and long-term prognosis in elderly patients with colorectal cancer, as well as support for nutrition interventions.
Low and moderate perceived social support linked to higher mortality in postmenopausal women with CRC.
Increases seen across the U.S., in men and women, in whites and blacks, for colon and rectal cancers.
